DoW Lupus, Transformative Vision Development Award
About
Summary: This funding mechanism supports planning and development activities and pilot studies that will generate preliminary data and demonstrate feasibility for achieving the aims of a future interventional study. Successful studies may be submitted to a future Lupus Research Program (LRP) Transformative Vision Award (TVA), or equivalent, for funding consideration (See Funding Opportunity Number HT942526LRPTVA for additional information). Research must address at least one of the fiscal year 2026 (FY26) LRP Transformative Vision Development Award (TVDA) focus areas. This funding mechanism allows for phase 0/1 clinical trials, if appropriate. The mechanism does not allow for phase 2/3 clinical trials or animal studies. Distinctive Features: • Preliminary data are permitted but not required. • Applications must include at least one lupus consumer advocate as a member of the research team. • An individual may be named as Principal Investigator (PI) on only one application per LRP award mechanism (Idea Award, Impact Award, TVDA, TVA), for a maximum of four applications to the FY26 LRP.
The DoW Lupus Transformative Vision Development Award supports researchers and clinical teams working to advance lupus treatment and understanding through innovative planning, development activities, and pilot studies. This grant is designed for investigators who want to generate preliminary data and demonstrate feasibility for future interventional studies in lupus research. The program encourages interdisciplinary teams that include lupus consumer advocates, ensuring patient perspectives shape research priorities. Researchers can pursue phase 0/1 clinical trials if appropriate to their study design. This funding mechanism is ideal for early-stage research projects that show promise but need foundational work before scaling to larger clinical trials. By supporting transformative approaches to lupus care and management, this award helps bridge the gap between initial concepts and fully-funded research initiatives. Successful projects may advance to the Lupus Research Program's Transformative Vision Award for continued funding. Applicants should align their research with fiscal year 2026 LRP focus areas and be prepared to demonstrate how their work will impact lupus patients and advance the field.
Funding Facts
● Applications openDeadline
August 24, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Not specified—varies by cycle
Deadline
2026-08-24
Grant Type
federal
Application Cycle
Annual (FY26 deadline: August 24, 2026)
Best For
Lupus researchers, clinical investigators, interdisciplinary research teams including patient advocates
Frequently Asked Questions
Who is eligible for DoW Lupus, Transformative Vision Development Award?
Specific eligibility criteria have not been provided in available information. However, applicants must include at least one lupus consumer advocate as a member of their research team. Individual researchers may serve as Principal Investigator on only one application per LRP award mechanism (with a maximum of four applications to the FY26 LRP across all mechanisms). For complete and current eligibility requirements, visit the official Department of Defense Lupus Research Program website or contact the program directly.
How much funding does DoW Lupus, Transformative Vision Development Award provide?
Funding amounts are not specified in the available program information. Award amounts vary by cycle and project scope. For specific funding ranges and budget limitations for this funding cycle, consult the official Department of Defense Lupus Research Program announcement and guidelines.
How do I apply for DoW Lupus, Transformative Vision Development Award?
Applications are submitted through the Department of Defense's official grants portal. The application deadline for FY26 is August 24, 2026. Applications must include a research team with at least one lupus consumer advocate. For detailed application instructions, required forms, submission procedures, and any technical assistance, visit the official DoD Lupus Research Program website or contact the program office directly.
What can DoW Lupus, Transformative Vision Development Award funding be used for?
This award supports planning and development activities, pilot studies, and phase 0/1 clinical trials (if appropriate). Funding generates preliminary data and demonstrates feasibility for future interventional lupus studies. Research must address at least one of the FY26 LRP Transformative Vision Development Award focus areas. The mechanism does not support phase 2/3 clinical trials or animal studies. Preliminary data is permitted but not required for applications.
Last updated: July 5, 2026